Staphylococcus Aureus Bacteraemia in Adults

NCT02098850 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2014-12-03

No results posted yet for this study

Summary

The purpose of this evaluation is to record the management and outcome of adults with S.aureus bacteraemia (SAB) across multiple European, Asian and North American sites and to identify key quality indicators associated with improved outcome.

Conditions

  • Staphylococcus Aureus Bacteremia

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Principal Investigators

  • Achim J Kaasch, MD · University of Cologne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2015-05-31
Completion
2016-05-31

Countries

  • Germany
  • South Korea
  • Spain
  • Taiwan
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02098850 on ClinicalTrials.gov